Brendan is currently looking for post-doctoral positions to begin in mid-2024" Brendan Wilkins on the

Alastair Brown (Sosei Heptares), where she is currently a final year Ph.D. student.

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

She is also very active within the pharmacology community and currently serves on the editorial board

She is currently working on her senior thesis which involves identifying the non-canonical signaling

Cellular Pharmacology Department at the University of Miami Miller School of Medicine in 2016, where he is currently

His current interests include the development of HTS fluorescence-based kinetic binding assays specifically

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine.

Proteinase Activated Receptor (PAR) Cleavage to Osteoarthritis (OA) Severity About Amr Mousa "I am currently Currently, I am engaged in postdoctoral research in the laboratory of Dr. Scott Prosser.

Hauser Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen

About Gavin Zhang Gavin is a currently a director of business and operations at Novoprotein Scientific

for a Ph.D. at the MRC Laboratory of Molecular Biology and the University of Cambridge, where he is currently

He is currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of

She is currently working to understand the signaling and degradation of GPCRs in disease states to help

I am currently funded by a postdoctoral fellowship from Wellcome Trust, working on a collaborative project

Research in my lab is currently focused on understanding the signal transduction pathways activated by

He currently leads a team that provides a mechanistic understanding of small molecule drug candidates

He currently leads a team that provides a mechanistic understanding of small molecule drug candidates

regulating antitumor immunity and tumorigenesis, therapeutic applications targeting GPCRs in oncology are currently

Aaron is currently the Chief Scientific Officer and VP of Protein Engineering.

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with

Currently, many drugs available on the market act via GPCRs and these receptors remain attractive targets

We are also currently developing the translational component of our research to capitalize on the druggability

He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists

Arun is currently an Associate Professor & Joy Gill Chair Professor, Intermediate Fellow, Wellcome Trust

His current focus is to realise Antiverse’s mission: engineering the future of drug discovery."